BAY-2416964

N/A

Report date: 2023/10/06 20:05:25
NME

Base Information

Drug NameBAY-2416964
Drug Alias NameBAY-2416964
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAryl hydrocarbon receptor antagonists
TargetsAryl hydrocarbon receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A